Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2019 Genitourinary Cancers Symposium

14 - 16 Feb 2019
Moscone West Building, San Francisco, United States of America
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate ...
Prof Karim Fizazi, Dr Eleni Efstathiou
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou )
15 Mar 2019
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma
Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )
19 Feb 2019
KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clea...
Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA
KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma ( Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA )
19 Feb 2019
Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metast...
Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA
Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )
19 Feb 2019
Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladde...
Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK
Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation ( Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK )
18 Feb 2019
Penile squamous cell carcinoma is genomically similar to other HPV-driven tumour...
Dr Jad Chahoud - MD Anderson Cancer Center, Houston, USA
Penile squamous cell carcinoma is genomically similar to other HPV-driven tumours ( Dr Jad Chahoud - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019
CB-839 in combination with cabozantinib in patients with clear cell and papillar...
Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019
KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patien...
Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA
KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC ( Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA )
18 Feb 2019
Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical cystec...
Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA
Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical cystectomy: Urothelial carcinoma subgroup analysis ( Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA )
18 Feb 2019
CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced rena...
Prof Nizar Tannir - MD Anderson Cancer Center, Houston, USA
CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced renal cell carcinoma ( Prof Nizar Tannir - MD Anderson Cancer Center, Houston, USA )
16 Feb 2019
ASCO GU 2019: Updates on treatment and management of bladder cancer
Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt...
ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )
15 Feb 2019
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer
Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mott...
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )
15 Feb 2019
STREAM trial: Enzalutamide and androgen deprivation therapy with salvage radiati...
Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA
STREAM trial: Enzalutamide and androgen deprivation therapy with salvage radiation in men with high-risk PSA recurrent PC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )
15 Feb 2019
Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised p...
Dr Nicholas van As - The Royal Marsden NHS Foundation Trust, London, UK
Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised prostate cancer ( Dr Nicholas van As - The Royal Marsden NHS Foundation Trust, London, UK )
15 Feb 2019
Updates on metastatic bladder cancer from ASCO GU 2019
Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA
Updates on metastatic bladder cancer from ASCO GU 2019 ( Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA )
15 Feb 2019
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carc...
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2019
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC
Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA
ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC ( Prof Andrew Armstrong - Duke Cancer Institute, Durham, USA )
14 Feb 2019
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
Sacituzumab govitecan in patients with previously treated metastatic urothelial ...
Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA
Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )
14 Feb 2019
Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma
Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada
Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma ( Dr Jean-Michel Lavoie - BC Cancer, Vancouver, Canada )
14 Feb 2019
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer
Dr Arjun Balar - NYU Langone Health, New York City, USA
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )
14 Feb 2019
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemot...
Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC ( Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy )
14 Feb 2019